1. Home
  2. PCVX vs PAM Comparison

PCVX vs PAM Comparison

Compare PCVX & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • PAM
  • Stock Information
  • Founded
  • PCVX 2013
  • PAM 1945
  • Country
  • PCVX United States
  • PAM Argentina
  • Employees
  • PCVX N/A
  • PAM N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • PAM Electric Utilities: Central
  • Sector
  • PCVX Health Care
  • PAM Utilities
  • Exchange
  • PCVX Nasdaq
  • PAM Nasdaq
  • Market Cap
  • PCVX 4.4B
  • PAM 3.8B
  • IPO Year
  • PCVX 2020
  • PAM N/A
  • Fundamental
  • Price
  • PCVX $36.24
  • PAM $73.94
  • Analyst Decision
  • PCVX Strong Buy
  • PAM Buy
  • Analyst Count
  • PCVX 10
  • PAM 3
  • Target Price
  • PCVX $136.50
  • PAM $85.83
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • PAM 209.3K
  • Earning Date
  • PCVX 08-05-2025
  • PAM 08-06-2025
  • Dividend Yield
  • PCVX N/A
  • PAM N/A
  • EPS Growth
  • PCVX N/A
  • PAM 32.60
  • EPS
  • PCVX N/A
  • PAM 0.41
  • Revenue
  • PCVX N/A
  • PAM $1,970,436,590.00
  • Revenue This Year
  • PCVX N/A
  • PAM $23.47
  • Revenue Next Year
  • PCVX N/A
  • PAM $22.99
  • P/E Ratio
  • PCVX N/A
  • PAM $7.05
  • Revenue Growth
  • PCVX N/A
  • PAM 21.62
  • 52 Week Low
  • PCVX $27.66
  • PAM $38.58
  • 52 Week High
  • PCVX $121.06
  • PAM $97.55
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 55.76
  • PAM 54.91
  • Support Level
  • PCVX $35.25
  • PAM $68.97
  • Resistance Level
  • PCVX $37.95
  • PAM $72.94
  • Average True Range (ATR)
  • PCVX 1.54
  • PAM 3.40
  • MACD
  • PCVX 0.14
  • PAM 0.46
  • Stochastic Oscillator
  • PCVX 72.24
  • PAM 82.30

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About PAM Pampa Energia S.A.

Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.

Share on Social Networks: